186 related articles for article (PubMed ID: 35203050)
1. Generation of a human iPSC line (UUIGPi015-A) from a patient with Dravet syndrome and a 2.9 Mb deletion spanning SCN1A on chromosome 2.
Schuster J; de Guidi C; Tripathi R; Klar J; Dahl N
Stem Cell Res; 2022 Apr; 60():102712. PubMed ID: 35203050
[TBL] [Abstract][Full Text] [Related]
2. Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations.
Schuster J; Fatima A; Sobol M; Norradin FH; Laan L; Dahl N
Stem Cell Res; 2019 Aug; 39():101523. PubMed ID: 31400703
[TBL] [Abstract][Full Text] [Related]
3. The Generation of Human iPSC Lines from Three Individuals with Dravet Syndrome and Characterization of Neural Differentiation Markers in iPSC-Derived Ventral Forebrain Organoid Model.
Zayat V; Kuczynska Z; Liput M; Metin E; Rzonca-Niewczas S; Smyk M; Mazurczak T; Goszczanska-Ciuchta A; Leszczynski P; Hoffman-Zacharska D; Buzanska L
Cells; 2023 Jan; 12(2):. PubMed ID: 36672274
[TBL] [Abstract][Full Text] [Related]
4. Generation of SCN1A Knock out induced pluripotent stem cell (iPSC) line.
Shan W; Yang X; Ren Q; Wang Q
Stem Cell Res; 2021 Aug; 55():102452. PubMed ID: 34247112
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a human induced stem cell line (FUi002-A) from Dravet syndrome patient carrying heterozygous R1525X mutation in SCN1A gene.
Tanaka Y; Higurashi N; Shirasu N; Yasunaga S; Moreira KM; Okano H; Hirose S
Stem Cell Res; 2018 Aug; 31():11-15. PubMed ID: 29981888
[TBL] [Abstract][Full Text] [Related]
6. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
[TBL] [Abstract][Full Text] [Related]
7. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
Miller AR; Hawkins NA; McCollom CE; Kearney JA
Genes Brain Behav; 2014 Feb; 13(2):163-72. PubMed ID: 24152123
[TBL] [Abstract][Full Text] [Related]
8. A novel variant in SCN1A gene associated with Dravet syndrome.
Pathirana B; Hettiarachchi D; Neththikumara NF; Ratnayake PD; Dissanayake V
Seizure; 2019 Jul; 69():213-214. PubMed ID: 31102827
[No Abstract] [Full Text] [Related]
9. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
[TBL] [Abstract][Full Text] [Related]
10. Genetic therapeutic advancements for Dravet Syndrome.
Chilcott E; Díaz JA; Bertram C; Berti M; Karda R
Epilepsy Behav; 2022 Jul; 132():108741. PubMed ID: 35653814
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomes of Dravet syndrome iPSC derived GABAergic cells reveal dysregulated pathways for chromatin remodeling and neurodevelopment.
Schuster J; Laan L; Klar J; Jin Z; Huss M; Korol S; Noraddin FH; Sobol M; Birnir B; Dahl N
Neurobiol Dis; 2019 Dec; 132():104583. PubMed ID: 31445158
[TBL] [Abstract][Full Text] [Related]
12. Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies.
Mei D; Cetica V; Marini C; Guerrini R
Epilepsia; 2019 Dec; 60 Suppl 3():S2-S7. PubMed ID: 31904125
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and comorbidities of SCN1A-related seizure disorders.
de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Sinoo C; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
Epilepsy Behav; 2019 Jan; 90():252-259. PubMed ID: 30527252
[TBL] [Abstract][Full Text] [Related]
14. Life-span characterization of epilepsy and comorbidities in Dravet syndrome mice carrying a targeted deletion of exon 1 of the Scn1a gene.
Gerbatin RR; Augusto J; Boutouil H; Reschke CR; Henshall DC
Exp Neurol; 2022 Aug; 354():114090. PubMed ID: 35487274
[TBL] [Abstract][Full Text] [Related]
15. Defining Dravet syndrome: An essential pre-requisite for precision medicine trials.
Li W; Schneider AL; Scheffer IE
Epilepsia; 2021 Sep; 62(9):2205-2217. PubMed ID: 34338318
[TBL] [Abstract][Full Text] [Related]
16. Establishment of isogenic iPSCs from an individual with SCN1A mutation mosaicism as a model for investigating neurocognitive impairment in Dravet syndrome.
Maeda H; Chiyonobu T; Yoshida M; Yamashita S; Zuiki M; Kidowaki S; Isoda K; Yamakawa K; Morimoto M; Nakahata T; Saito MK; Hosoi H
J Hum Genet; 2016 Jun; 61(6):565-9. PubMed ID: 26841829
[TBL] [Abstract][Full Text] [Related]
17. Genetic Diagnosis of Dravet Syndrome Using Next Generation Sequencing-Based Epilepsy Gene Panel Testing.
Lee J; Lee C; Park WY; Lee J
Ann Clin Lab Sci; 2020 Sep; 50(5):625-637. PubMed ID: 33067208
[TBL] [Abstract][Full Text] [Related]
18. Generation of D1-1 TALEN isogenic control cell line from Dravet syndrome patient iPSCs using TALEN-mediated editing of the SCN1A gene.
Tanaka Y; Sone T; Higurashi N; Sakuma T; Suzuki S; Ishikawa M; Yamamoto T; Mitsui J; Tsuji H; Okano H; Hirose S
Stem Cell Res; 2018 Apr; 28():100-104. PubMed ID: 29453127
[TBL] [Abstract][Full Text] [Related]
19. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009.
Bayat A; Hjalgrim H; Møller RS
Epilepsia; 2015 Apr; 56(4):e36-9. PubMed ID: 25778844
[TBL] [Abstract][Full Text] [Related]
20. Generation of corrected-hiPSC (USTCi001-A-1) from epilepsy patient iPSCs using TALEN-mediated editing of the SCN1A gene.
Zhao H; He L; Li S; Huang H; Tang F; Han X; Lin Z; Tian C; Huang R; Zhou P; Huang J; Deng S; Li Z
Stem Cell Res; 2020 Jul; 46():101864. PubMed ID: 32544858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
